Selected Publications

Kaplan S.V., Limbocker R.A., Levant B., Johnson M.A.* “Regional differences in dopamine release in R6/2 Huntington’s disease model mice” Electroanalysis 2018, 30(6):1066-1072

Field T.M., Shin M., Stucky C.S., Loomis J., Johnson M.A.* “Electrochemical Measurement of Dopamine Release and Uptake in Zebrafish Following Treatment with Carboplatin,” ChemPhysChem 2018, 19(10):1192-1196

Shin M., Field T.M., Furgerson M.N., Stucky C.S., Johnson M.A.* “Dopamine release and uptake in zebrafish whole brain ex vivo.” ACS Chem Neurosci. 2017, 8(9):1880-1888

Sofis M.J., Jarmolowicz D.P., Kaplan S.V., Gehringer R.C., Lemley S.M., Garg G., Blagg B.S., Johnson M.A. “KU32 prevents 5-fluorouracil induced cognitive impairment.” Behav Brain Res. 2017, 329:186-190. Featured in major news outlets, including: Science Daily, Medical News Today, UPI

Kaplan S. V., Limbocker R. A., Divis J. L., Osterhaus G. L., Newby M. D., Sofis M. J., Jarmolowicz D. P., Newman B. D., Mathews T. A., Johnson M.A.* “Impaired Brain Dopamine and Serotonin Release and Uptake in Wistar Rats Following Treatment with Carboplatin.”ACS Chem. Neurosci. 2016, 7(6):689-699. ACS Editor’s Choice Award, Featured on the journal cover, Featured in Chemical & Engineering News, 94(21), May 23, 2016. Featured in other major news outlets, including:Science Daily, MedicalResearch.com, MedicalxPress, Neuroscience News.

Shin M., Kaplan S.V., Raider K.D., Johnson M.A.* “Simultaneous measurement and quantitation of 4-hydroxyphenylacetic acid and dopamine with fast-scan cyclic voltammetry,” Analyst. 2015, 140(9):3039-3047.

Sun, M., Johnson, M.A.* “Measurement of total antioxidant capacity in sub-μL blood samples using craft paper-based analytical devices,” RSC Advances. 2015, 5(69):55633-55639.  

Sun M., Kaplan S. V., Gehringer R. C., Limbocker R. A., Johnson M. A.*“Localized drug application and sub-second voltammetric dopamine release measurements in a brain slice perfusion device,” Anal. Chem. 2014, 86(9):4151-4156.

Kaplan, S. V., Fowler S. C., Johnson M. A.* “Measurements of Dopamine Release and Uptake in Huntington’s Disease Model Rodents” (2014) Compendium of In Vivo Monitoring in Real-Time Molecular Neuroscience ed. G.S. Wilson and A.C. Michael (World Scientific Publishing: Hackensack, NJ) pp 311-329.

Shin M, Kaplan SV, Newby M, Johnson M. A.* Conference Report: Pittcon 2013: microfluidics, electrochemistry, and much much more. Bioanalysis. 2013, 5(16):1965-7

Johnson M. A.* In vivo electrochemical measurements: past, present and future. Bioanalysis. 2013, 5(2):119-22

Ortiz, A. N., Osterhaus, G. L., Lauderdale, K. A., Selley, P. S., Fowler, S. C., von Horsten, S., Riess, O., and Johnson, M. A.* “Motor function and dopamine release measurements in transgenic Huntington's disease model rats,” Brain Res. 2012, 1450:148-56.

Ortiz, A. N., Kurth, B. J., Osterhaus, G. L., Johnson, M. A.*, “Impaired dopamine release and uptake in R6/1 Huntington's disease model mice,” Neurosci Lett. 2011, 492(1):11-14

Ortiz, A. N., Oien, D. B., Moskovitz, J., Johnson, M. A.* “Quantification of reserve pool dopamine in methionine sulfoxide reductase A null mice.” Neuroscience. 2011, 177:223-9

Fulks, J. L., O'Bryhim, B. E., Wenzel, S. K., Fowler, S. C., Vorontsova, E., Pinkston, J. W., Ortiz, A. N., Johnson, M. A.* “Dopamine release and uptake impairments and behavioral alterations observed in mice that model fragile X mental retardation syndrome,” ACS Chem Neurosci. 2010, 1(10):679-690.

Oien, D. B., Ortiz, A. N., Rittel, A. G., Dobrowsky, R. T., Johnson, M. A., Levant, B, Fowler, S. C., Moskovitz, J. “Dopamine D2 receptor function is compromised in the brain of the methionine sulfoxide reductase A knockout mouse,” J. Neurochem. 2010, 114, 51-61.

Ortiz, M. A., Kurth, B. J., Osterhaus, G. L., Johnson, M. A.* “Dysregulation of intracellular dopamine stores revealed in the R6/2 mouse striatum,” J. Neurochem. 2010, 112, 755-761.

Miller, B.R., Walker, A. G., Fowler, S. C., von Horsten, S., Riess, O., Johnson, M. A., Rebec, G. V. “Dysregulation of coordinated firing patterns in striatum of freely behaving transgenic rats that model Huntington’s disease,” Neurobiology of Disease, 2010, 37, 106-113.

Fowler S. C., Miller B. R., Gaither T. W., Johnson M. A., Rebec G. V., “Force-plate quantification of progressive behavioral deficits in the R6/2 mouse model of Huntington’s disease,” Behav. Brain Res. 2009, 202(1):130-7.

Kraft, J. C., Osterhaus, G. L., Ortiz, A. N., Garris, P. A., Johnson, M. A.*, “In vivo dopamine release and uptake impairments in rats treated with 3-nitropropionic acid,” Neuroscience, 2009, 161(3):940-9.

Oien, D. B., Osterhaus, G. L., Latif, S. A., Pinkston, J. W., Fulks,  J., Johnson, M. A., Fowler, S. C., Moskovitz, J.  “MsrA knockout mouse exhibits abnormal behavior and brain dopamine levels,” Free Rad. Biol. Med. 2008, 45(2):193-200.

Wilson, G. S. and Johnson, M. A. “In vivo electrochemistry:  what can we learn about living systems?” Chem. Rev. 2008, 108(7), 2462-2481.

Jain, H. D., Zhang, C., Zhou, S., Zhou, H., Ma, J., Liu, X., Liao, X., Deveau, A. M., Dieckhaus, C. M., Johnson, M. A., Smith, K. S., Macdonald, T.L., Kakeya, H., Osada, H., Cook, J.M. “Synthesis and structure-activity relationship studies on tryprostatin A, an inhibitor of breast cancer resistance protein,” Bioorg. Med. Chem. 2008, 16(8), 4626-4651.

Johnson, M. A., Villanueva, M., Haynes, C. L., Seipel, A. T, Buhler, L. A., and Wightman, R. M., Catecholamine exocytosis is diminished in the R6/2 mouse model of Huntington’s disease, J. Neurochem., 2007,103(5), 2102-10.

Johnson, M. A., Rajan, V., Miller, C. E., and Wightman, R. M. “Dopamine release is severely compromised in the R6/2 mouse model of Huntington’s disease,” J. Neurochem., 2006, 97(3), 737-746.

Schonhoff, C. M., Matsuoka, M., Tummala, H., Johnson, M. A., Estevez, A., Kamaid, A., Ricart, K., Hashimoto, Y., Gaston, B., Macdonald, T. L., Xu, Z., and Mannick, J. B. “Aberrant denitrosylation in amyotrophic lateral sclerosis,” Proc. Nat. Acad. Sci.(USA), 2006 Feb 14;103(7), 2404-2409.

Johnson, M. A. and Macdonald, T. L. “Accelerated CuZn-SOD-mediated oxidation and reduction in the presence of hydrogen peroxide,” Biochem. Biophys. Res. Commun. 2004, 324(1), 446-450.

Heien, M. L. A. V., Johnson, M. A., and Wightman, R. M. “Resolving neurotransmitters detected by fast-scan cyclic voltammetry," Anal. Chem. 2004, 76(19), 5697-5704.

Zhao, S, Smith, K. S.,  Deveau, A. M., Dieckhaus, C. M., Johnson, M. A., Macdonald, T. L., and Cook, J. “Biological activity of the tryptostatins and their diastereomers on human carcinoma cell lines,” J. Med. Chem. 2002, 45(8), 1559-1562

Snyder, A. H., Mcpherson, M. E., Hunt, J. F., Johnson, M., Stamler, J. S., and Gaston, B. M. “Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis,” Am. J. Respir. Crit. Care Med. 2002, 165, 1-5.

Lipton, A. J., Johnson, M. A., Macdonald, T., Lieberman, M. W., Gozal, D., Gaston, B., Ponka, P., Kim, S. “S-nitrosothiols control breathing and oxygen homeostasis,” Redox Report 2002, 7(1), 5-7.

Johnson, M. A., Macdonald, T. L., Mannick, J. B., Conaway, M. R., and Gaston, B. “Accelerated S-nitrosothiol breakdown by amyotrophic lateral sclerosis mutant copper, zinc-superoxide dismutase,” J. Biol. Chem. 2001, 276, 39872-39878.

Lipton, A. J., Johnson, M. A., Macdonald, T., Lieberman, M. W., Gozal, D., and Gaston, B. “S-nitrosothiols signal the ventilatory response to hypoxia,” Nature 2001, 413, 171-174.   Featured in News and Views.

Dieckhaus, C. M., Roller, S. G., Johnson, M. A., Smith, K. S., Miller, T. A., Sofia, R. D., and Macdonald, T. L. “Felbamate metabolite patient urinalysis to monitor potential drug-induced idiosyncratic reactions,”  EpilepsiaAccepted, then withdrawn for proprietary reasons.

Zapien, D. Z. and Johnson, M. A. “Direct electron transfer of ferritin adsorbed at bare gold electrodes,” J. Electroanal. Chem. 2000, 494(2), 114-120.


Johnson Group News
KU Today
One of 34 U.S. public institutions in the prestigious Association of American Universities
44 nationally ranked graduate programs.
—U.S. News & World Report
Top 50 nationwide for size of library collection.
—ALA
23rd nationwide for service to veterans —"Best for Vets," Military Times